ISN’s 0by25 initiative for AKI (zero preventable deaths by 2025): a human rights case for nephrology

In 2015, ISN’s fight against AKI has continued to gain strength. In March, during the World Congress of Nephrology, the Lancet launched a major new Commission on the ISN 0by25 Initiative, endorsing ISN goal to eliminate preventable deaths from AKI by 2025. 

The article, which appeared in the 27 June printed edition of the Lancet, was written by ISN leaders and members and presents the global challenges of the AKI burden and sets out the key goals and future activities of the 0by25 initiative. 

Further insights were produced in response to the launch of the Commission in Capetown and ISN’s fight against AKI, including a dedicated Offline article by The Lancet Editor-in-Chief Richard Horton and this commentary written by Richard Horton and Philippa Berman.

Prof Ravindra L Mehta, MD?†?, Prof Jorge Cerd?, MD†, Prof Emmanuel A Burdmann, MD†, Prof Marcello Tonelli, MD†,Prof Guillermo Garc?a-Garc?a, MD, Prof Vivekanand Jha, MD, Paweena Susantitaphong, MD, Prof Michael Rocco, MD, ProfRaymond Vanholder, MD, Prof Mehmet Sukru Sever, MD, Dinna Cruz, MD, Prof Bertrand Jaber, MD, Prof Norbert H Lameire, MD, Prof Ra?l Lombardi, MD, Andrew Lewington, MD, Prof John Feehally, MD, Prof Fredric Finkelstein, MD, ProfNathan Levin, MD, Neesh Pannu, MD, Bernadette Thomas, MD, Eliah Aronoff-Spencer, MD, Prof Giuseppe Remuzzi, MD

The Lancet, Volume 385, No. 9987, p2616–2643, 27 June 2015

Additional Info

  • Language:
  • Contains Audio:
  • Content Type:
  • Source:
    Other sources
  • Year:
  • Members Only:

Read 316 times

Last modified on Wednesday, 07 October 2015 18:41

Scroll to Top